NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
July 11, 2006 • Volume 3 / Number 28 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer

Director's Update
A Shared Commitment to a Global Problem

Spotlight
New DNA Analyzer Reveals Rare Mutations in Tumors

Cancer Research Highlights
Varenicline Helps More Smokers Quit for Longer with Fewer Side Effects

Survivors of Childhood Cancer Risk Premature Menopause

Biomarker IMP3 Predicts Kidney Cancer Metastasis and Survival

Chornobyl Nuclear Accident's Impact on Thyroid Cancer Risks

Funding Opportunities

Featured Clinical Trial
Studying Dyskeratosis Congenita

Notes
Malone Among Finalists for Career Achievement Medal

Monograph on Uses of Dosimetry in Radiation Epidemiology Now Available

FDA Launches New Monitoring Initiative

CCR Grand Rounds

Guest Commentary by Dr. John R. Seffrin
Bridging the Gap: Turning What We Know About Cancer into What We Do About Cancer

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities Funding Opportunities

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health (NIH) is available at http://calendar.nih.gov.
Following is a newly released NCI research funding opportunity:

Research on Research Integrity
Announcement Number: RFA-NR-07-001
Letter of Intent Receipt Date: August 14, 2006.
Application Receipt Date: September 14, 2006.

This funding opportunity will use the R01 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3500. Inquiries: Dr. Alexis D. Bakos - bakosa@mail.nih.gov

For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov